Evidence map›Paper›PMID 40507936›Full record

ArticleInternational journal of molecular sciences2025

Low-Dose Salinomycin Alters Mitochondrial Function and Reprograms Global Metabolism in Burkitt Lymphoma.

Aleksandra Zdanowicz, Oleksandr Ilchenko, Andrzej Ciechanowicz, Haoyu Chi, Marta Struga, Beata Pyrzynska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aleksandra ZdanowiczDepartment of Biochemistry, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland.ORCID 0000-0002-0875-2608
Oleksandr IlchenkoDepartment of Forest Genetics and Plant Physiology, Umeå Plant Science Centre, Swedish University of Agricultural Sciences, Skogsmarksgränd 17, 90183 Umea, Sweden.
Andrzej CiechanowiczDepartment of Regenerative Medicine, Center for Preclinical Research and Technology, Medical University of Warsaw, Banacha 1B Str., 02-097 Warsaw, Poland.
Haoyu ChiDepartment of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, UK.ORCID 0009-0008-8954-6240
Marta StrugaDepartment of Biochemistry, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland.ORCID 0000-0002-0181-3607
Beata PyrzynskaDepartment of Biochemistry, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland.ORCID 0000-0002-0490-618X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salinomycin (SAL), originally identified for its potent antibacterial properties, has recently garnered attention for its remarkable activity against a variety of cancer types. Beyond its direct cytotoxic effects on cancer cells, SAL can also enhance the efficacy of anti-CD20 immunotherapy in B-cell malignancies, both

Indexed as

Antineoplastic AgentsBurkitt LymphomaMitochondriaPyransCell Line, TumorGlycolysisHumansMembrane Potential, MitochondrialOxidative StressPolyether PolyketidesReactive Oxygen SpeciesAntineoplastic AgentsPolyether PolyketidesPyransReactive Oxygen Speciessalinomycinmetabolomicsmitochondriamitochondrial respirationoxidative stresssalinomycin

Identifiers

PMID40507936
PMCPMC12155122

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.